Evidence map›Paper›PMID 28025971›Full record

ArticleRevista espanola de salud publica2017

[Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].

Rafael Gómez Navarro, Paloma González García, Carlos Martín Hernández, Ángel Castro Sauras, Santiago Valdearcos Enguídanos

Open access · greenAbstract read
In one paragraph

Article in Revista espanola de salud publica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Rafael Gómez NavarroCentro de Salud Teruel Centro. Teruel. España.
Paloma González GarcíaHospital San José. Teruel. España.
Carlos Martín HernándezHospital Universitario Miguel Servet. Zaragoza. España.
Ángel Castro SaurasHospital Obispo Polanco. Teruel. España.
Santiago Valdearcos EnguídanosDirección Atención Primaria Sector Teruel. Teruel. España.
Hospital Obispo Polanco · ESHospital Terrassa · ESHospital Universitario Miguel Servet · ESPublic Risk Management Association · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOsteoporosis should be prevented, diagnosed and treated, preferably before the fragility fracture occurs. The objective was to analyze primary and secondary interventions carried out in individuals diagnosed with femur fragility fracture at Teruel in 2014.

methodsDescriptive retrospective study. Variables assessed were sex, age, main health district, place of residence, basal functional situation, diagnosis on osteoporosis, hip or vertebral fracture, loss of height, use of FRAX tool, treatment on discharge, survival and cause of exitus. Student's t-test and ANOVA were used for quantitative variables by categories and regression for linear relationships.

results148 patients were included. 123 were women median age was 87 years, 123 (76,4%) were women, 27,4% of the patients were totally or severely dependent for activities of daily living and 33% of them were living in a nursing home. There was a previous history of hip fracture in 10,1%, and one or more vertebral fractures in 10,1%. FRAX® tool was not used in any case. 12,2% of patients had been treated with calcium prior to fracture, 11,5% with vitamin D, and 6,8% of them with antiosteoporotic drugs. Only 52,7% were treated for secondary prevention after discharge. At the end of follow-up, 25,7% of hip fractured patients had died. Median survivorship of deceased patients was 64,5 days. 42,3% of exitus were caused by cardiovascular disease, 23,1% by infection and 11,5% by neoplasms.

conclusionsPrimary pharmacologic prevention and assessment of osteoporosis or risk of fracture are unfrequent in our health district.. Although pharmacologic treatment is prescribed more frequently in Teruel than in other areas after a hip or vertebral fracture, additional measures should be taken in order to improve fragility fracture prevention.

Indexed as

AgedAged, 80 and overBone Density Conservation AgentsCross-Sectional StudiesFemaleHip FracturesHumansMaleOsteoporosisOsteoporotic FracturesPractice Patterns, Physicians'Primary PreventionRetrospective StudiesSecondary PreventionSpainTreatment OutcomeBone Density Conservation AgentsAgingFrail ElderlyHip fractureOsteoporosisosteoporosis, age relatedPrimary Health CarePrimary-preventionSpain

Identifiers

PMID28025971
PMCPMC11587323
OpenAlexW3023109456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.